The stock price of CVS Health Corp (NYSE: CVS) has surged by 11829885 when compared to previous closing price of 66.84, but the company has seen a 0.33% gain in its stock price over the last five trading sessions. prnewswire.com reported 2025-06-23 that Company commits to distinctive actions that will make it easier to navigate the health care system, access care, and achieve better health HARTFORD, Conn., June 23, 2025 /PRNewswire/ — Aetna, a CVS Health company (NYSE: CVS), today announced its support of initiatives championed by American’s Health Insurance Plans to improve the experience of doctors and patients.
Is It Worth Investing in CVS Health Corp (NYSE: CVS) Right Now?
CVS Health Corp (NYSE: CVS) has a price-to-earnings ratio that is above its average at 15.90x. The stock has a 36-month beta value of 0.56. Opinions on the stock are mixed, with 13 analysts rating it as a “buy,” 8 as “overweight,” 7 as “hold,” and 0 as “sell.”
The public float for CVS is 1.26B, and at present, short sellers hold a 1.22% of that float. On June 23, 2025, the average trading volume of CVS was 9.99M shares.
CVS’s Market Performance
CVS stock saw an increase of 0.33% in the past week, with a monthly gain of 4.44% and a quarterly increase of -3.02%. The volatility ratio for the week is 0.53%, and the volatility levels for the last 30 days are 1.23% for CVS Health Corp (CVS). The simple moving average for the last 20 days is 3.62% for CVS stock, with a simple moving average of 10.90% for the last 200 days.
Analysts’ Opinion of CVS
Many brokerage firms have already submitted their reports for CVS stocks, with Leerink Partners repeating the rating for CVS by listing it as a “Outperform.” The predicted price for CVS in the upcoming period, according to Leerink Partners is $75 based on the research report published on February 13, 2025 of the current year 2025.
CVS Trading at 2.09% from the 50-Day Moving Average
After a stumble in the market that brought CVS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -8.19% of loss for the given period.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CVS starting from SANSONE GUY P, who purchase 1,570 shares at the price of $63.70 back on Jun 05 ’25. After this action, SANSONE GUY P now owns 12,007 shares of CVS Health Corp, valued at $100,009 using the latest closing price.
ROBBINS LARRY, the Director of CVS Health Corp, sale 2,276,068 shares at $67.86 during a trade that took place back on May 02 ’25, which means that ROBBINS LARRY is holding 9,670,731 shares at $154,444,758 based on the most recent closing price.
Stock Fundamentals for CVS
Current profitability levels for the company are sitting at:
- 0.03 for the present operating margin
- 0.14 for the gross margin
The net margin for CVS Health Corp stands at 0.01. The total capital return value is set at 0.06. Equity return is now at value 7.00, with 2.09 for asset returns.
Based on CVS Health Corp (CVS), the company’s capital structure generated 0.51 points at debt to capital in total, while cash flow to debt ratio is standing at 0.11. The debt to equity ratio resting at 1.06. The interest coverage ratio of the stock is 3.18.
Currently, EBITDA for the company is 13.68 billion with net debt to EBITDA at 4.8. When we switch over and look at the enterprise to sales, we see a ratio of 0.41. The receivables turnover for the company is 9.56for trailing twelve months and the total asset turnover is 1.48. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.82.
Conclusion
To sum up, CVS Health Corp (CVS) has seen a better performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”.
